CGON CG Oncology Inc Sotuvning yalpi rentabelligi

CGON (CG Oncology Corp) - kompaniyaning tovar belgisi

Barqaror geosiyosiy muhit CG Oncology, Inc. (CGON) rivojlanishini qo'llab-quvvatlaydi, buni tushumlar doirasidagi yalpi foyda marjasi dinamikasi tasdiqlaydi, bunda -106.20 ushbu parametrning qiymatini ko'rsatadi. Biroq, tashqi moliyalashtirishga bog'liqlik va klinik muvaffaqiyatsizliklar xavfi tufayli biznes zaifligicha qolmoqda. Ushbu holat kasallikning turli bosqichlarini qamrab oluvchi qovuq saratoni terapiyasiga strategik e'tibor qaratish orqali yumshatilmoqda.

CG Oncology Corp (CGON): Yalpi rentabellik 21.02.2024dan 20.11.2026gacha

CG Oncology Inc (CGON) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:CGON (CG Oncology Corp)
CG Oncology tayyor mahsulotlari

Investitsiya xatarlarini minimallashtirish uchun sotilgan tovarlar tannarxini chegirib tashlagandan keyin qolgan tushum ulushini tahlil qilish orqali bevosita xarajatlarni boshqarish samaradorligini baholash zarur. Valo kredit marjalarining tarixini o'rganish orqali investor CG Oncology, Inc. (CGON) kompaniyasining innovatsion saraton terapiyasiga bo'lgan talabni sof foydaga aylantirish qobiliyatini aniqlaydi, bu esa biznesning barqaror yuqori likvidlilikni yaratish bosqichiga o'tganini tasdiqlaydi.

Muhim raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|UroGen Pharma - Sotuvning yalpi rentabelligi|Bicara Therapeutics - Yalpi foyda bo'yicha rentabellik|Yalpi marja Personalis Inc PSNL|Erasca Oncology - Yalpi marja|Yalpi foyda normasi DCTH (Delcath Corp)|YMAB: Yalpi marja|AURA - Yalpi foyda bo'yicha sotuv rentabelligi|CADL (Candel Therapeutics Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi ARAY (Accuray)|Yalpi foyda bo'yicha rentabellik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Yalpi foyda marjasi|Yalpi rentabellik Citius Oncology, Inc. CTOR|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik